We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Top Buys

Rank Stock Value
1
RMGC
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
+$19.5M
2
META icon
Meta Platforms (Facebook)
META
+$14M
3
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$12.6M
4
CNC icon
Centene
CNC
+$9.33M
5
VMW
VMware, Inc
VMW
+$9.33M

Top Sells

Rank Stock Value
1
ADMA icon
ADMA Biologics
ADMA
+$21.8M
2
Y
Alleghany Corp
Y
+$20.1M
3
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$20M
4
GACQ
Global Consumer Acquisition Corp. Common Stock
GACQ
+$17.4M
5
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$14.4M

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QBTS.WS
1851
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$38.6K ﹤0.01%
26,779
-4,481
-14% -$932
AIBBR
1852
DELISTED
AIB Acquisition Corp Right
AIBBR
$38.5K ﹤0.01%
350,000
– –
ONFO icon
1853
Onfolio Holdings
ONFO
$422K
$38K ﹤0.01%
25,000
– –
EMCGR
1854
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$37.9K ﹤0.01%
+346,875
New +$33.4K
OKUR
1855
OnKure Therapeutics
OKUR
$168M
$37.2K ﹤0.01%
1,597
– –
RFACR
1856
DELISTED
RF Acquisition Corp. Rights
RFACR
$37K ﹤0.01%
400,000
– –
TTI icon
1857
CALL
TETRA Technologies
TTI
$1.27B
$35.8K ﹤0.01%
80,800
+7,700
+11% +$29.9K
XFOR icon
1858
X4 Pharmaceuticals
XFOR
$393M
$35.8K ﹤0.01%
1,203
-756
-39% -$35.8K
CLRCR
1859
DELISTED
ClimateRock Right
CLRCR
$34.5K ﹤0.01%
300,000
– –
BRTX icon
1860
BioRestorative Therapies
BRTX
$5.31M
$33.8K ﹤0.01%
12,296
-19,704
-62% -$61.4K
BLCM
1861
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$32.4K ﹤0.01%
45,057
– –
ASCBR
1862
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$31.5K ﹤0.01%
450,000
– –
BCLI
1863
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$31.3K ﹤0.01%
1,273
– –
ASLN
1864
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$29.8K ﹤0.01%
2,069
– –
ARIZR
1865
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$28.8K ﹤0.01%
330,000
– –
CPTNW
1866
DELISTED
Cepton, Inc. Warrant
CPTNW
$28.7K ﹤0.01%
22,591
– –
NEXRW
1867
Nexera Technologies Ltd Warrant
NEXRW
$41.4K
$27.9K ﹤0.01%
24,038
– –
CLOER
1868
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$27.8K ﹤0.01%
347,800
– –
PRST
1869
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$27.8K ﹤0.01%
12,127
-14,569
-55% -$33K
GLLIR
1870
DELISTED
Globalink Investment Inc. Rights
GLLIR
$27.4K ﹤0.01%
542,850
+2,850
+0.5% +$248
FXCOR
1871
DELISTED
Financial Strategies Acquisition Corp. Rights
FXCOR
$26.8K ﹤0.01%
350,000
– –
IGTAR
1872
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$23.8K ﹤0.01%
250,000
– –
LGHLW
1873
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$23.5K ﹤0.01%
32,895
– –
SYBX
1874
DELISTED
Synlogic
SYBX
$23.5K ﹤0.01%
2,058
– –
CNTB
1875
Connect Biopharma Holdings
CNTB
$138M
$23.3K ﹤0.01%
26,867
– –
73 74
75
76 77

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.